Literature DB >> 21713318

Role of vitamin K-dependent proteins in the arterial vessel wall.

M L L Chatrou1, C P Reutelingsperger, L J Schurgers.   

Abstract

Vitamin K was discovered early last century at the same time as the vitamin K-antagonists. For many years the role of vitamin K was solely ascribed to coagulation and coagulation was thought to be involved only at the venous blood side. This view has dramatically changed with the discovery of vitamin K-dependent proteins outside the coagulation cascade and the role of coagulation factors at the arterial side. Vitamin K-dependent proteins are involved in the regulation of vascular smooth muscle cell migration, apoptosis, and calcification. Vascular calcification has become an important independent predictor of cardiovascular disease. Vitamin K-antagonists induce inactivity of inhibitors of vascular calcification, leading to accelerated calcification. The involvement of vitamin K-dependent proteins such as MGP in vascular calcification make that calcification is amendable for intervention with high intake of vitamin K. This review focuses on the effect of vitamin K-dependent proteins in vascular disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21713318     DOI: 10.5482/ha-1157

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


  14 in total

Review 1.  Vitamin K status in chronic kidney disease: a report of a study and a mini-review.

Authors:  Kieran Voong; Dominic Harrington; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2013-01-08       Impact factor: 2.370

2.  Deuterium-labeled phylloquinone fed to α-tocopherol-injected rats demonstrates sensitivity of low phylloquinone-containing tissues to menaquinone-4 depletion.

Authors:  Sherry M Farley; Scott W Leonard; Jan F Stevens; Maret G Traber
Journal:  Mol Nutr Food Res       Date:  2014-07-14       Impact factor: 5.914

3.  Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein.

Authors:  Kelly E Beazley; Saman Eghtesad; Maria V Nurminskaya
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

4.  Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells.

Authors:  J-K Tie; D-Y Jin; K Tie; D W Stafford
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

5.  VKORC1 rs2359612C allele is associated with increased risk of coronary artery disease in the presence of coronary calcification.

Authors:  Yibo Wang; Jinxing Chen; Yu Zhang; Lv Bin; Kai Sun; Weifeng Yu; Jibin Liu; Channa Zhang; Haiqing Shen; Zhihui Hou; Fangfang Yu; Rutai Hui
Journal:  Hum Genet       Date:  2012-08-23       Impact factor: 4.132

6.  VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.

Authors:  Abdessalem Hammed; Benjamin Matagrin; Gabriele Spohn; Caroline Prouillac; Etienne Benoit; Virginie Lattard
Journal:  J Biol Chem       Date:  2013-08-08       Impact factor: 5.157

7.  Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin.

Authors:  Kelly E Beazley; Steven Reckard; Dmitry Nurminsky; Florence Lima; Maria Nurminskaya
Journal:  J Biol Chem       Date:  2013-09-13       Impact factor: 5.157

8.  Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women.

Authors:  Toshiro Sato; Leon J Schurgers; Kazuhiro Uenishi
Journal:  Nutr J       Date:  2012-11-12       Impact factor: 3.271

9.  γ-Glutamyl carboxylase mutations differentially affect the biological function of vitamin K-dependent proteins.

Authors:  Zhenyu Hao; Da-Yun Jin; Xuejie Chen; Leon J Schurgers; Darrel W Stafford; Jian-Ke Tie
Journal:  Blood       Date:  2021-01-28       Impact factor: 25.476

10.  Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype.

Authors:  Leon J Schurgers; Ivo A Joosen; Eduard M Laufer; Martijn L L Chatrou; Marjolein Herfs; Mark H M Winkens; Ralf Westenfeld; Verena Veulemans; Thilo Krueger; Catherine M Shanahan; Willi Jahnen-Dechent; Erik Biessen; Jagat Narula; Cees Vermeer; Leonard Hofstra; Chris P Reutelingsperger
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.